| | |
| |
| |
| |
| |
|
![]() |
|
|
![]() | |||||||
|
|
|
| ||||||||
|
|
|
| ||||||||
The Institutional Review BoardBeginning on November 1, 2005, Western
IRB (WIRB) will be the IRB of record for all corporate-sponsored clinical
trials (with a very few exceptions such as PI-initiated studies). Marty
Barrows will coordinate the process of sending the initial application
to WIRB. Please see the Human
Subjects Office site to learn about submitting to WIRB. For studies that will be reviewed by the University's IRB: When submitting documents to the Clinical Trials Office, it is wise to
submit your application to the Institutional Review Board (IRB) at the
same time. Our two offices maintain close contact, often alerting each
other about an upcoming study. In addition, although it is not mandatory,
in order to avoid confusion it is highly advisable that the Principal
Investigator on the study be the Principal Investigator on the IRB application.
Be advised that, if your IRB application is approved before the contract is executed, the Human Subjects Office will not release the approved documents until the CTO has notified them that the contract has been fully executed. The two offices will also interact to ensure that research-related injury language is consistent in the contract and the consent document. IRB Workshop Schedule The purpose of The IRB Workshop is to familiarize staff with UI policies and procedures governing the use of human subjects in research. The Human Subjects Office will do the following:
If Company Requests IRB Roster The company may request a roster of IRB members who reviewed their protocol. Rosters are available on the web page of the Human Subjects Office. (top) |